Cargando…
Biomarkers for isolated congenital heart disease based on maternal amniotic fluid metabolomics analysis
INTRODUCTION: Congenital heart disease (CHD) is one of the most prevalent birth defects in the world. The pathogenesis of CHD is complex and unclear. With the development of metabolomics technology, variations in metabolites may provide new clues about the causes of CHD and may serve as a biomarker...
Autores principales: | Yuan, Xuelian, Li, Lu, Kang, Hong, Wang, Meixian, Zeng, Jing, Lei, Yanfang, Li, Nana, Yu, Ping, Li, Xiaohong, Liu, Zhen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9677635/ https://www.ncbi.nlm.nih.gov/pubmed/36404327 http://dx.doi.org/10.1186/s12872-022-02912-2 |
Ejemplares similares
-
Analysis of Biomarkers for Congenital Heart Disease Based on Maternal Amniotic Fluid Metabolomics
por: Li, Yahong, et al.
Publicado: (2021) -
Metabolomics of Human Amniotic Fluid and Maternal Plasma during Normal Pregnancy
por: Orczyk-Pawilowicz, Magdalena, et al.
Publicado: (2016) -
Amniotic fluid biomarkers predict the severity of congenital cytomegalovirus infection
por: Vorontsov, Olesya, et al.
Publicado: (2022) -
Association between congenital heart defects and maternal manganese and iron concentrations: a case–control study in China
por: Wang, Meixian, et al.
Publicado: (2021) -
Maternal environmental, occupational, and urinary metabolite levels of benzene compounds and their association with congenital heart diseases in offspring: a case‒control study in China
por: Wang, Meixian, et al.
Publicado: (2023)